Ceribell, Inc. (CBLL): Cash & Equivalents
$40.48M
As of 2025-12-31
$32.66M
As of 2026-06-30
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $40.48M | -79.2% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $194.37M | +463.5% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $34.49M | n/a | 2025-02-25, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | 2025-12-31 | $40.48M | -79.2% |
| Vaso Corp (VASO) | 2025-12-31 | $35.05M | +33.4% |
| Biolife Solutions Inc (BLFS) | 2025-12-31 | $33.04M | -63.9% |
| Electromed, Inc. (ELMD) | 2026-06-30 | $20.45M | +33.8% |
| Outset Medical, Inc. (OM) | 2025-12-31 | $35.01M | -71.8% |
| Iridex Corp (IRIX) | 2026-01-03 | $6.03M | +152.5% |
| Axogen, Inc. (AXGN) | 2025-12-31 | $35.55M | +29.0% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $13.42M | +9.9% |
| electroCore, Inc. (ECOR) | 2025-12-31 | $7.04M | +90.1% |
Compare CBLL, VASO, BLFS, ELMD side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗